Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)
- Previous Close
6.48 - Open
6.50 - Bid 6.66 x --
- Ask 6.67 x --
- Day's Range
6.50 - 6.77 - 52 Week Range
5.73 - 9.66 - Volume
8,798,184 - Avg. Volume
7,781,790 - Market Cap (intraday)
2.507B - Beta (5Y Monthly) 0.39
- PE Ratio (TTM)
-- - EPS (TTM)
-0.22 - Earnings Date --
- Forward Dividend & Yield 0.02 (0.31%)
- Ex-Dividend Date Jun 13, 2024
- 1y Target Est
--
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, tablets, capsules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 1978 and is based in Pinghu, China.
www.zjspas.com1,385
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 603168.SS
View MorePerformance Overview: 603168.SS
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603168.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603168.SS
View MoreValuation Measures
Market Cap
2.51B
Enterprise Value
2.54B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.85
Price/Book (mrq)
1.49
Enterprise Value/Revenue
5.03
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-16.77%
Return on Assets (ttm)
-2.28%
Return on Equity (ttm)
-4.75%
Revenue (ttm)
505.58M
Net Income Avi to Common (ttm)
-84.79M
Diluted EPS (ttm)
-0.22
Balance Sheet and Cash Flow
Total Cash (mrq)
198.96M
Total Debt/Equity (mrq)
13.76%
Levered Free Cash Flow (ttm)
-65.54M